SEC Form 4 · accession 0001225208-15-011624
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward J Ludwig
Director
Period of report
May 5, 2015
Accepted (ET)
May 7, 2015 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF2,F1,F3 | — | May 5, 2015 | A | 5,325 | A | — | — | Common Stock | 5,325 | 18,502 | D |
| Stock Option (Right to Buy)F4 | $17.37 | May 5, 2015 | A | 16,818 | A | — | May 5, 2025 | Common Stock | 16,818 | 16,818 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Reflects a value of $92,500 divided by the closing price of common stock on the date of grant.
- F3Reporting person elected to receive half of the annual equity award of $185,000 in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
- F4Reporting person elected to receive half of the annual equity award of $185,000 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the next annual meeting of stockholders.